Caccamo et al. reported that in a mouse model of Alzheimer’s disease (AD), depletion of one copy of S6k1 significantly reduced amyloid-β and tau pathology, two neuropathological hallmarks for AD, accompanied by improvements in synaptic plasticity and spatial memory [61]. This evidence concerns the gene MAPT and Alzheimer disease.